Home/Filings/4/0001415889-25-003821
4//SEC Filing

Heerma Peter 4

Accession 0001415889-25-003821

CIK 0001438533other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 9:25 PM ET

Size

11.5 KB

Accession

0001415889-25-003821

Insider Transaction Report

Form 4
Period: 2025-02-10
Heerma Peter
CHIEF COMMERCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-10+8,000130,708 total
  • Sale

    Common Stock

    2025-02-11$25.00/sh3,074$76,850127,634 total
  • Sale

    Common Stock

    2025-02-12$23.53/sh2,568$60,426125,066 total
  • Exercise/Conversion

    Performance-based restricted stock units

    2025-02-108,0000 total
    Common Stock (8,000 underlying)
Footnotes (4)
  • [F1]On January 31, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 8,000 shares of the Issuer's common stock, to vest upon the satisfaction of certain clinical/regulatory performance criteria. On February 10, 2025, the PSUs vested upon the Issuer's confirmation that the clinical/regulatory performance criteria had been satisfied, including confirming a path forward for submitting an sNDA for traditional approval of FILSPARI (sparsentan) in FSGS.
  • [F2]Each PSU represents a contingent right to receive one share of the common stock of the Issuer.
  • [F3]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • [F4]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.

Issuer

Travere Therapeutics, Inc.

CIK 0001438533

Entity typeother

Related Parties

1
  • filerCIK 0001789617

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 9:25 PM ET
Size
11.5 KB